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INTRODUCTION 
 
 
 Rheumatoid Arthritis (RA) in this commonest form of chronic 
inflammatory joint disease.  It is a symmetrical, non supportive 
polyarticular disease unique to modern man.1 
  
Rheumatoid arthritis affects the synovial joints, but it is not 
confined to them and the many visceral manifestations have led to the 
classification of RA as a systemic disorder of the immunological 
mechanism. 
  
Of the systemic lesions, anemia and a focal subcutaneous 
granuloma are the most characteristic. Some cases of RA, particularly 
those that are seropositive, are fulminating and rapidly progress to severe 
deformity.1 
 
 
 
 
 
 
 
 
 
 
 
 
 
REVIEW OF LITERATURE 
 
 
HISTORICAL REVIEW 
 Historical review revealed that Hippocrates and other Greek and 
Roman writers gave possible descriptions of the disease (Short, 1974).  
There are suggestive descriptions in the Sanskrit writings of Charaka 
Samhita of 100 AD (Sturrack et al. 1977) and by the 17th century English 
Physician, Thomas Sydenham (short 1974). 
 
 Sydenham described the diseases state which he called 
“Rheumatoid Polyarthritis”.  But it was clearly described by landre-
Beauvais (1800).  Garrod (1859) used the term “Rheumatoid Arthritis” 
and a clinical description of the disease entity began to emerge. The 
modern concept of the disease evolved by the pain-staking work of 
Nicholes and Richardson (1906), Jones, Milard Smith (1930), Lewis 
Faning, Short, Bauer and Reynold (1957).  Short’s text book (1957) set 
the stage for the modern era of investigation and inquiry in the field of 
clinical rheumatology.  American Rheumatism Association carefully 
drafted the description and the criteria for the diagnosis of Rheumatoid 
Arthritis. 
 
 
 
DEFINITION 
 
 Rheumatoid Arthritis is a chronic, symmetrical, inflammatory, 
deforming polyarthritis affecting small and large peripheral joints with 
associated systemic disturbance such as vasculitis and nodules.  
Characteristically the course of the disease is prolonged with 
exacerbations and remissions. (2) 
 
 
 
 
 
 
 
 
 
 
 
 
GENERAL ASPECTS OF RHEUMATOID ARTHRITIS 
 
EPIDEMIOLOGY 
 Rheumatoid Arthritis occurs throughout the world and in all ethnic 
groups.  Its prevalence is approximately 1 percent of the population 
(range 0.3 to 2.1 percent); women are affected approximately three times 
more often than men.  The prevalence increases with age and sex 
differences diminish in the old age group. The onset is more frequent 
during the fourth and fifth decade of life, with 80% of all patients 
developing the disease between the ages of 35 and 50. (2) 
 
AETIOLOGY 
 Rheumatoid Arthritis is a disease determined by genetic and 
environmental factors, namely an infectious agent which is systemically 
distributed in the patient, but has a particular predilection for synovial 
joints. 
 
 
GENETIC FACTORS 
 Family and mono and dizygotic twin studies have shown that there 
is a genetic factor in Rheumatoid Arthritis.  Severe Rheumatoid Arthritis 
is found at approximately four times the expected rate in first degree 
relative of individual with seropositive disease. (2) 
 Moreover 30% of monozygous twins are concordant for 
Rheumatoid Arthritis whereas only 5% of dizygous twins are concordant. 
 
 In Rheumatoid Arthritis the important observation was the finding 
that HLA-D4 and HLA-DR4 are significantly elevated, being found in 
60-80% of patients compared to 20% of control subjects.  (Panayi et al, 
1978; Stastny, 1978). This is true for all populations except Israel & India 
where the association is with HLA-DR1 (Schiff et al, 1982). 
 
Environmental Factor 
 Increasing urbanization and industrialization in Europe from 18th 
century onwards led to the spread of rheumatic diseases.  Such a 
demographic change with a change in the prevalence of Rheumatoid 
Arthritis seems to have been observed in South Africa. 
 
 The urban factor involves alteration in diet, living conditions and 
exposure to new environmental agents both microbial and chemical.  
Indirect evidence for such environmental factor comes from the work of 
Wasmuth et al (1972) who showed that the probability of the non-
consanguineous spouse of a proband with Rheumatoid Arthritis 
developing the disease was related to the length of time the two 
individuals had lived together. 
 
INFECTION-PATHOGENESIS  
 Rheumatoid Arthritis is characterized by persistent cellular 
activation, autoimmunity and the presence of immune complexes at sites 
of articular and extra-articular lesions. 
 
Evidence suggesting RA as autoimmune disease1 
1) Hypergammaglobulinemia 
2) Presence of variety of auto antibodies especially Rheumatoid 
Factor. 
3) Presence of circulating and deposited immune complexes. 
4) Cryoglobulins. 
5) Plasma cells in bone marrow 
6) Central lymphoid organs and synovial membrane making 
rheumatoid factor. 
7) Infiltration of the synovial membrane with mononuclear chronic 
inflammatory cells, especially lymphocytes. 
 
The central question concerns the mechanism whereby the 
autoimmunity is switched on.  There are those who postulate that 
initiation of the disease is a genetically determined failure to IgG while 
others maintain that external agents or factors activate autoimmunity to 
IgG by the breaking of tolerance through a variety of mechanisms such as 
excessive helper activity, loss of suppressor activity and activation of 
macrophages (Carson, 1982).  Recent experimental work has 
demonstrated that the production of antiglobulins and antinuclear factors 
is a very prominent component of a normal immune response although 
the physiological function of such auto antibodies is not known.  (dresser, 
1978; Steele & Cunningham, 1978).1 
 
 In Rheumatoid arthritis there is evidence of abnormal immune 
reactivity in the bone marrow, lymph nodes and spleen as well as in the 
synovial membrane itself. 
 
 As a consequence of the persistence of the Rheumatoid Arthritis 
Agent and the consequent chronic stimulation of the immune response, a 
variety of auto antibodies are formed and in particular rheumatoid factor.  
These factors and their ability to form immune complexes are thought to 
be responsible for some of the inflammatory lesions especially the 
extraarticular features, seen during the course of the disease.  Some of the 
immune complexes formed locally in the joint while others may be 
formed in the circulation with subsequent deposition in the tissues. 
 
 
 
 
 
Disease in the joints 
 The earliest lesion in Rheumatoid Arthritis involves the blood 
vessels running through the synovium, followed by the perivascular 
accumulation of lymphocytes and lastly by changes in the synovial lining 
cell layer. 
 
 This leads to swelling and congestion of the synovial membrane 
and the underlying connective tissues, which become infiltrated with CD4 
T cells, macrophages and plasma cells.  Some 70% of the latter are 
producing IgG and IgM rheumatoid factors.  Immune complexes are 
present in abundance both extra cellularly and intracellularly either as 
phagocytosed material or as self associated IgG rheumatoid factors within 
the plasma cells (Munthe, 1978). 
 
 Effusion of synovial fluid into joint space takes place during active 
phases of the disease.  Hypertrophy of the synovial membrane occurs 
with the formation of lymphoid follicles resembling an immunologically 
active lymph node.  Inflammatory granulation tissue (Pannus) is formed, 
spreading over and under the articular cartilage which is progressively 
eroded and destroyed. 
 
 Later, fibrous adhesions may form between the layers of pannus 
across the joint space and fibrous or bony ankylosis may occur.  Muscles 
adjacent to inflamed joints atrophy and there may be focal infiltration 
with lymphocytes.  
 
Extra Articular Diseases 
 The most frequent tissue lesion is the subcutaneous granulomata.  
It is histologically more characteristic (Moore & Wilikens, 1977).  These 
are found in 20% cases, usually seropositive. 
 
 Subcutaneous nodules have a characteristic histological 
appearance.  There is a central area of fibrinoid material consisting of 
swollen and fragmented collagen fibers, fibrinous exudates and cellular 
debris, surrounded by a palisade or radically arranged proliferating 
mononuclear cells.  The nodules have a loose capsule of fibrous tissue.3 
 
 Similar granulamatous lesion may also occur in the pleura, lung, 
pericardium and sclera. Lymph nodes are often hyperplastic, showing 
many lymphoid, follicles with large germinal centers and numerous 
plasma cells in the sinuses and medullary cords.  Immunofluorescence 
shows that plasma cells in the synovium and lymph nodes synthesize 
rheumatoid factors. 
 
 
The 1987 Revised Criteria for the Classification of Rheumatoid 
Arthritis4 
I. Guideline for Classification 
Four of seven criteria are required to classify a patient as having 
Rheumatoid Arthritis. 
 
II. Criteria 
1. Morning stiffness – stiffness in and around the joints lasting one 
hour before maximal improvement. 
 
2. Arthritis of three or more joint areas. 
At least three joint areas, observed by a physician 
simultaneously, have soft tissue swelling or joint effusions, not just 
bony growth.  The 14 possible joint areas involved are right or left 
proximal interphalangeal, metacarpophalangeal, wrist, elbow, and 
knee, ankle, and metatarsophalangeal joints. 
 
3. Arthritis of hand joints 
Arthritis of wrist, metacarphophalangeal joint, or proximal 
interphalangeal joint. 
 
 
 
 
 
 
4. Symmetric arthritis 
Simultaneous involvement of the same joint areas on both 
sides of the body. 
 
5. Rheumatoid Nodules 
Sub cutaneous nodules over bony prominences, extensor 
surfaces, or juxtaarticular regions observed by a physician.  
 
6. Serum rheumatoid factor 
Demonstration of abnormal amounts of serum rheumatoid 
factor by any method for which the result has been positive in less 
than 5% of normal control subjects. 
 
7. Radiographic changes 
Typical changes of Rheumatoid Arthritis on poster anterior 
hand and wrist radiograph which must include erosions or unequivocal 
bony decalcification localized in or most marked adjacent to the 
involved joints. 
 
 *Criteria 1-4 must be present for atleast 6 weeks.  Criteria 2-5 must   
be observed by a physician. 
 
 
 
Articular Manifestations of Rheumatoid Arthritis 
 The onset of the disease is usually insidious especially in the 4th 
and 5th decades.  Occasionally the onset may be acute as in Still’s disease 
with high grade fever, evanescent rash, leucocytosis, lymphadenopathy, 
spleenomegaly, pleuritis and pericarditis (Bywaters, 1971; Esdaile et al 
1980). More commonly the arthritis is polyarticular and symmetrical 
from the outset (Hernandez et al 1980).  The test for rheumatoid factor is 
usually positive at this state (Jacoby et al 1973).  The traditional view is 
that small peripheral joints are affected first, but in one large study large 
joints were affected first in 52% of patients (Short et al 1957). 
 
 Regarding prognosis, as per one study, upto one quarter of the 
patients had inactive disease and functional ability and another quarter 
had only mild to moderate activity with only slight functional 
impairment.  The remaining patients, however, had persistent disease 
activity and were severely crippled (Short and Bauer 1948; Ragan 1949; 
Short et al 1957; Duthie etal 1964). 
 
 Patients with persistently high titers of rheumatoid factor have in 
general a poor prognosis, whereas those with low titers or intermittently 
weakly positive rheumatoid factor tests run a favorable course (Duthie et 
al, 1964; Feigenbaum et al, 1979). 
 The clinical features of the arthritis conform to the cardinal features 
of inflammation with the exception-redness is never present.  A red 
rheumatoid joint always must be suspected as being infected usually with 
staphylococcus aureus and demands immediate arthrocentesis. (Kellgren 
et al 1958; Karten 1971; Huskisson and Hart 1972). 
 
 Joint stiffness is especially troublesome in the morning, attributed 
to increased fluid content of the joint tissues (Scott 1960).  Stiffness after 
sitting for some time is also very characteristic of rheumatoid arthritis, 
although also found in other forms of inflammatory joint disease (Wright 
and Plunkett, 1966). 
 
 The joints most frequently involved are the proximal 
interphalangeal joints of the fingers, the interphalangeal joints of the 
thumbs, the metacarpophalangeal joints, the wrist, elbow and shoulder 
joints, the knee joints and metatarsophalangeal joints in the feet.  The 
pattern of joint involvement is so often symmetrical (Jacoby et al 1973; 
Fleming et al 1976 a, b) typically the distal interphalangeal joints are 
spared.4 
 
 Involvement of the temporomadibular joints and the cervical spine 
are commonly present as early features in the disease presentation 
(Fleming et al 1976).  Severe disease is generally associated with early 
wrist and metatarsophalangeal joint involvement. 
 
Clinical Features of the Joints of Hand and Wrist in Rheumatoid 
Arthritis 
Dorsal Surface 
1. Synovial Hypertrophy of the wrist joint. 
2. Extensor tendon and extensor pollicis longus involvement. 
3. Prominence of the ulnar styloid. 
4. Wasting of the dorsal interossei 
5. Involvement of the metacarpophalangeal joints with ulnar deviation. 
6. Involvement of the proximal interphalangeal joints with ‘Buttonhole’ 
and ‘Swan-neck’ deformities. 
7. The typical z-shaped deformity of the thumb. 
 
Volar Surface 
1. Swelling along flexor sheaths and ‘trigger finger’ 
2. Heaping up of the flexor retinaculam, with compression of median 
and ulnar nerves. 
3. Wasting of intrinsic muscles due to median or ulnar nerve 
compression or peripheral neuropathy. 
 
Systemic Manifestations of Rheumatoid Arthritis 
 The commonest non-articular manifestation of Rheumatoid 
Arthritis in the granulomatous nodule, which is characteristically found 
near the olecranon process in 20 to 30% of patients with ‘definite’ or 
‘classical’ Rheumatoid Arthritis as defined by the American Rheumatism 
Association.  (Ropes et al, 1959).  It can also occur over scalp, sacrum, 
scapula, Achilles tendon, fingers and toes. 
 
 Vasculitis – Arterial inflammation is often clinically silent, but 
when severe and extensive may cause dermal infarction, peripheral 
neuropathy, perforation or gangrene of the bowel and even myocardial 
infarction.  (Webb & Payne, 1970; Lind – say et al, 1973).  
Approximately 5 to 10% of all Rheumatoid Arthritis patients, especially 
females will develop leg ulcers at some time of their illness. 
 
 In respiratory system, pulmonary involvement is important.  
Caplan syndrome consists of nodular opacities varying in size from 0.5 to 
5 cm throughout both lungs in a patient with Rheumatoid Arthritis or in a 
subject with minimal or no Rheumatoid Arthritis but with positive tests 
for rheumatoid factor (Miall et al, 1953; Caplan et al, 1962).  Interstitial 
fibrosis, pleurisy, pleural effusion and pleuropulmonary nodules can also 
occur. 
 Heart involvement in Rheumatoid Arthritis include granulomatous 
infiltration of myocardium and conducting system, valvular insufficiency 
(Carpenter et al, 1967) pericarditis and myocardial failure. 
 
 In eye keratoconjunctivitis sicca occurs in about 10% of patients 
with Rheumatoid Arthritis (Bloch et al, 1965).  Episcleritis and Scleritis 
also occur. 
 
 Sjogren syndrome comprises the triad-dry eyes of 
keratoconjunctivitis sicca, xerostomia with or without salivary gland 
enlargement and in one-half to two-third of patients a connective tissue 
disease, usually Rheumatoid Arthritis.  (Bloch et al, 1965; Whaley et al, 
1973 a, b). 
 
 Neurological manifestations may result from atlantoaxial or 
midcervical spine subluxations, entrapment neuropathy of median, ulnar, 
radial or anterior tibial nerves, mononeuritis multiplex and peripheral 
neuropathy. 
 
 Osteoporosis, muscle weakness and wasting may occur adjacent to 
inflamed joints. 
  
 
 
Hematological  involvement in rheumatoid arthritis 
The most common extra articular abnormality seen in patients with 
rheumatoid arthritis is anemia. This is usually a mild anemia that is either 
symptomatic or accompanied by slight fatigue. (Katyrin et al 1987). 
      Many patients with rheumatoid arthritis have an anemia which 
responds poorly to standard hematinic therapy. (Mowat et al 1971). 
Fortunately the degree of anemia is usually low and there is correlation 
between the severity of disease and depth of anemia (Grennan et al 
1975). 
Anemia in rheumatoid arthritis: 
1. Anemia of chronic disease 
2. Iron deficiency anemia due to  
(a) poor diet  
(b) Chronic blood loss due to treatment  
Salicylate-chronic blood loss  
Phenacetin - Methhemoglobinemia 
Heinz body hemolytic anemia                                          
Phenyl butazone-pancytopenia 
Gold-thrombocytopenia and pancytopenia 
(c) Significant bleeding in to the joint 
3. Folate, B12 deficiency due to drugs5 
 
   Anemia of chronic disease is present in 27% of outpatients 
followed for rheumatoid arthritis (5) and 50% of newly diagnosed patients 
admitted in wards. Anemia of chronic disease is normocytic or 
normochromic or slightly hypochromic. Bone marrow is usually normal 
except for slight under hemoglobinisation of mature precursors. (6), Iron 
stores are normal but sideroblasts are decreased. 
 Anemia of chronic 
 Disease 
Iron deficiency
anemia 
Fedeficiencywith
Inflammation 
MCV 72-100fl <85fl <100fl 
MCHC <36 <32 <32 
Serum iron  Decreased decreased Decreased 
TIBC Below mid normal 
 Range 
increased Less than upper 
limit of normal 
Transferrin sat. >20% <15% 15% 
Serum ferritin >35ng/ml <35ng/ml <200ng/ml 
Serum soluble 
transferring 
Receptor conc. 
Normal increased Increased 
Stainable iron in 
 bone marrow 
 
+ 
 
      __ 
 
__ 
 
     The pathogenesis of anemia in rheumatoid arthritis is complex. 
(Mowat et al 1971) 
 
Chronic administration of anti rheumatic drugs can lead to GI 
blood loss. (Scott et al 1961) 
 
    There is evidence that the incidence of macrocytic anemia is higher 
than expected in patients with rheumatoid arthritis largely owing to folate 
deficiency (Gough et al 1964) 
 
The pathogenesis of anemia in rheumatoid arthritis 
(1) Shortened red cell survival (Dinant etal 1978, Richmond etal 
1978) 
(2) Reduced serum and red cell folate  concentration (Omer 1968) 
(3) Impairment of compensatory increase in iron absorption in 
response to anemia(Boddy & will 1969) 
(4) Improved erythropoietin release in response to anemia (Ward et al 
1969) 
(5) Increased ineffective erythropoiesis(Dinanat etal 1978) 
(6) Synovial iron deposition (Muirden and senator 1967) 
(7) An abnormal pattern of iron handling characterized by rapid serum 
iron release and defective release of stored iron from 
reticuloendothelial system(Owen& Lawson1966, Bennet etal 
1974) 
(8) Suppression of proliferative capacity of erythroid bonemarrow by 
immune mechanisms by both humoral (Dainak etal 1980, 
Goldberg et al 1980)and cell mediated mechanism (Abodu et al 
1978) 
 Microcytosis <80 fl present in 2 to 8% anemia of chronic disease 
Most recent series states that it is present in 20 to 40%(7,8)of patients with 
rheumatoid arthritis.  
 Hypochromia (MCH < 26) is more common than microcytosis. It 
is present in 50-100% of patients with rheumatoid arthritis .Hypochromia 
is observed even though hematocrit remains normal . 
 
MCV<72fl is rare (9) 
 
RDW is typically elevated (9) 
 
Hypochromia typically precedes microcytosis in anemia of chronic 
disease but typically follows the development of microcytosis in iron 
deficiency.  
 
Algorithm for evaluation of anemia of chronic disease: 
 
 
 
 
 
                                                                                  
                                                          No                                          NO   
↑                                                                                                       
                                                                                                . 
 
 
 
                                                           NO 
                                                                                
                            
                                                                                                     ↑ 
                                                                                                        
 
                                 ↓yes 
 
 
 
Mechanism for anemia of chronic disease: 
 
 
(1) Shortened red cell survival 10,11 
 
(2) Impaired marrow response 
      (a)Impaired erythropoietin production 
       (b)Impaired marrow progenitor response to erythropoietin 
(3)Impaired mobilization of RE iron stores 
 
 
 
Serum Ferritin 
(<50 µg/dl) 
          yes 
Iron deficiency Anemia 
N0 
Serum ferritin>200 
Serum   sTfr  Assay 
Stainable iron in bone marrow 
Anemia of chronic 
        disease 
YES 
Iron deficiency Anemia 
        NO 
Anemia of chronic 
        disease 
↑sr. sTfr conc 
Shortened red cell survival 
Anemic patients with rheumatoid arthritis show inverse correlation 
between IL-1 level and red cell survival. (12, 13) There is a decrease in 
erythropoietin availability resulting in selective hemolysis of youngest 
red cells. Another mechanism described is increased generation of peroxy 
nitrite in red cells may enhance membrane rigidity and shortened red cell 
survival. The mean survival of RBC survival is 80 to 90 days compared 
to 100 to 120 days in normal persons. in rheumatoid arthritis.13,14  
 
Impaired erythropoietin production 
      There is an inverse correlation between serum erythropoietin level 
and hemoglobin, as hemoglobin decreases erythropoietin increases. For 
any given anemic individual with RA patients, erythropoietin level was 
lower than that found in equally anemic individuals with iron deficiency. 
Thus erythropoietin response to anemia was blunted in RA(15,  16, 17, 18). 
Impaired Erythropoietin response is due to cytokines like IL1, TNF α, 
TGF β  which inhibit the production of erythropoietin. (5) 
 
 
 
 
 
Impaired marrow response to erythropoietin: 
  Although erythropoietin levels of patients with ACD are not high 
as those in equally anemic patients with iron deficiency, these values are 
still higher than normal individuals who are not anemic. Other  factors 
like TNFα, IL-1, IFNγ also inhibits erythroid colony formation. 
TNF α was found to inhibit colony formation by erythroid colony 
forming units from BM mononuclear cells in a dose dependent fashion19). 
However colony formation by highly purified CFU-E generated from 
peripheral blood cells (300CFU-E) was not affected; indicating that 
TNFα action was indirect, which is likely to be mediated by  marrow 
stroma. Inhibition was mediated by soluble factors released from stroma, 
including IFNγ 20. Similarly inhibitory effect of IL-1 on CFU- E colony 
formation was also shown to be indirect and dependent on IFNγ released 
from T lymphocytes. IFN γ induces apoptosis in CFU-E  a process that 
requires Fas activation .Ceramide , a product of sphingomyelin 
hydrolysis, a mediator of apoptotic effects  of TNFα,IL1,IFN γ and is 
frequently implicated  in Fas mediated events.It is  either endogenous 
ceramide produced by exposure to bacterial sphingomyelinase or 
exogenous bacterial sphingomyelinase or exogenous cell permeable 
ceramide which significantly inhibits bonemarrow CFU- E derived 
colony formation. Exposure of marrow cells to IFN y lead to significant 
increase in ceramide content suggesting a role of ceramide. Nitric oxide, 
another potential 2nd messenger in cytokine effects, directly inhibits 
erythroid colony formation in vitro .Cytokines may alter the expression 
of hematopoeisis growth factor receptors during erythroid development 
as well. Exposure to 2500 u/ ml IFNγ in vitro resulted in a decrease in 
erythroid receptors for EPO and stem cell factor but not insulin like 
growth factor 1 probably mediated at the gene translation level. 
 
Impaired mobilization of Reticuloendothelial   iron store 
Impaired mobilization of reticuloendothelial  iron store is also 
from cytokine effects.IL1 increase the translation of ferritin messenger 
RNA 21, 22) and additional ferritin could act as a trap for iron that might 
otherwise be available for erythropoiesis. The acute phase reactant α1AT 
is inhibiting erythropoiesis impairing transferring binding to transferring 
receptor and subsequent internalization of Tfr  
Increase serum concentration of soluble transferring receptor may 
able to identify iron deficiency. 23,24 .Concentration of free protoporphyrin 
in erythrocytes tend to be elevated in patient with anemia of chronic 
disease. FEP increases more slowly in anemia of chronic disorder than it  
does in iron deficient and it does not become clearly abnormal with 
significant anemia has developed. Hepcidin is a acute phase reactant, anti 
microbial protein , regulator of iron storage and transport and has been 
proposed as a mediator of anemia of chronic disease. Recent studies have 
underlined the role of hepcidin, a peptide produced by hepatocytes, in the 
pathogenesis of ACD. Interleukin-6 produced at sites of inflammation or 
infection stimulates hepcidin production, an acute-phase protein, which 
causes sequestration of iron in reticuloendothelial cells and also decreases 
intestinal iron absorption [25]. Hence blocking hepcidin production may 
help in effective treatment of ACD.  
 
Eosinophilia 
Normally eosinophils are present  upto 5% of total WBC. 
Eosinophilia occurs in 40% in rheumatoid arthritis patients .(26) 
 
Large granular lymhocytosis syndrome 
  The subset of patients with rheumatoid arthritis has increased 
number of large granular lymphocytes in peripheral blood, bone marrow 
and liver. The lymphocytes contain many azurophilic granules in 
cytoplasm and may account for 90% mononuclear cells . In LGL, 1/3 rd 
have Rheumatoid arthritis .  LGL syndrome in patients with rheumatoid 
arthritis has same HLA DR 4 association as seen in Felty syndrome. (27) 
 
Platelet abnormalities 
Thrombocytosis is a common finding in acute and severe 
rheumatoid arthritis. .(28) It correlates with most parameters of disease 
activity such as ESR, WBC count, plasma viscosity, liver enzymes, 
rheumatoid factor and acute phase reactants (Farr et al 1983). 
Thrombocytopenia is not a feature of rheumatoid disease except in 
Felty syndrome or as a result of gold and D penicillamine therapy. 
Shortened platelet survival is found in a minority of patients with 
rheumatoid disease but these patients usually have normal or increased 
platelet count (Farr et al 1980; kelton et al 1983). 
   In patients with platelets greater than 10,00,000, an alternative 
causes of the thrombocytosis should be considered. 
 
NEUTOPENIA  
  In 1924 Felty described the clinical association of leucopenia, 
splenomegaly, and rheumatoid arthritis. Other features include 
lympadenopathy, weight loss, anemia, skin pigmentation, chronic leg 
ulceration. It occurs in  about 1% of patients  with rheumatoid arthritis.29  
   The pathogenesis of neutropenia is multifactorial. The following 
have been described.  
1. Antineutrophil antibodies 
2. Antigen-antibody complexes 
3. Myelosuppression by a humoral inhibitor as well as a mononuclear 
suppressor cell (Goldberg & pinals 1980;logue etal 1981; backnall et 
al 1982) 
 Hyperviscosity syndrome: 
Patients with high titres of rheumatoid factor have slightly 
increased serum  viscosity. Occasionally this may be marked and give 
rise to hyperviscosity syndrome. (Pope et al 1975; Cryer et al 1981) 
       The clinical features consist of dyspnoea, dizziness, ataxia 
diplopia, visual blurring, epistaxis, skin hemorrhages, menorrhagia and 
rectal bleeding. Examination of fundus reveals venous engorgement , blot 
hemorrhages, soft exudates and in severe cases papilloedma. 
 
Paraproteinemia 
It is typified by monoclonal gammopathies and it has poor 
prognostic significance when it appears in rheumatoid arthritis patients30  
 
Hematological  malignancies: 
There are conflicting reports on the risk of lymphoma and 
leukemia in patients with rheumatoid arthritis. The bulk of evidence 
suggests that the risk is increased. In review of 46,101 patients with 
rheumatoid arthritis, 130 cases of leukemia, lymphoma and myeloma 
were observed as compared to  59.6 cases expected in general population, 
which is statistically significant . (31) 
     There is an increased risk of hematologic malignancies in patients 
with  Sjogrens syndrome and probably in those with rheumatoid arthritis. 
In Sjogrens syndrome  the incidence  of  non Hodgkin’s lymphoma is 
more than 40 times of what is expected in the general population. 
 
Coagulation abnormalities: 
Conn et al 197632 found that elevated level of fibrinogen and FDP 
in patients with rheumatoid vasculitis. C.S Lau etal in  1993 found that 
VWF is elevated in patients with rheumatoid vasculitis. Pariaz et al33 
states that  some patients develop acquired “factor VIII inhibitors” and 
acquired hemophilia in rheumatoid arthritis patients .In their study  one 
patient  had decreased protein S and protein C . 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
AIMS AND OBJECTIVES 
 
 
(1) To study the hematological status in patients with rheumatoid 
arthritis. 
(2) To find out the prevalence of anemia in these patients and its 
correlation with seropositivity and disease activity which is 
measured by DAS 28 score(Disease activity score). 
(3) To know the prevalence of  iron deficiency anemia and anemia of 
chronic disease  among anemic patients of rheumatoid arthritis and 
its correlation with disease activity i.e DAS 28 score. 
(4) To analyse other hematological  parameters and its correlation with 
DAS 28 score. 
 
                                          
 
                 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Materials and Methods 
 
 
 Setting                     : Department of Medicine , Govt Rajaji hospital 
 
 Design                     : Cross-sectional study 
 
 Period of study       : One year study  
 
 Ethical approval     : Obtained from ethical committee approval headed     
                                   by Dean, Govt. Rajaji hospital 
 
 Consent                  : Obtained from all patients 
 
Statistical software   : EPI Info 2002 
 
 Study population  :   Patients attending Rheumatology OP- randomly  
      selected 
 
Inclusion criteria: 
 
        (1)Patients who satisfied the American Rheumatologic association 
criteria 1987, irrespective of hematological signs present or not . 
        (2)Age group 20 to 60 years irrespective of any sex. 
        (3) duration of disease upto 5 years 
 
Exclusion criteria: 
 
 (1)Previously diagnosed anemia and treated  
           (2)Previously have any other bleeding disorder not related to 
                Rheumatoid arthritis  
                  
     (3)Those who have mixed disorder like SLE and RA ;SS  & 
           RA and MCTD and overlap syndrome.    
     (4)previously knowm malignancies, renal failure, hemolytic anemia  
(5) any other chronic blood loss like hemorrhoids     
     
           Forty four patients of rheumatoid arthritis were selected from  
random basis for the study from rheumatology clinic , Govt. Rajaji 
hospital, Madurai. 
          The duration of illness was upto 5 years at different stages of 
rheumatoid arthritis. Patients with the age group ranging from 20 to 60 
years were studied. 
The selected patients were evaluated with detailed history 
regarding duration of disease and history of drug intake and type of onset 
of symptoms noted. 
 
           Presence of joint swelling, tenderness and deformities and number 
of tender joints and number of joint swelling  noted. Rheumatological 
functional class was assigned  clinically.  
 
 
 
Detailed clinical examination including pallor and rheumatoid 
nodule and lymphadenopathy.All systems are examined carefully and 
visual analogue pain score was  carefully assessed. 
 
          Hemoglobin, Red blood cell count, White blood cell count , 
Hematocrit,Differential count , MCV , MCH, MCHC , Platelet count ,  
RDW, MPV, Serum ferritin,  Total iron binding capacity, Serum iron, 
Peripheral smear, , Bleeding time ,  Clotting time, ESR,  Rheumatoid  
factor,  C reactive protein , Sugar, urea , creatinine, serum protein ,   
albumin and globulin  were done in laboratory. 
 
 
Automated hemogram was done to calculate blood cell counts 
through 3 part differential automated  coulter cell counter. 
 
         Most automated counters measure hemoglobin by modification of 
manual hemoglobin cyanide method.Red blood cells and other blood cells 
were counted electronically in systems based on  light scattering 
technology. 
 
A three part differential count assigns cells to categories usually 
designated (1) granulocytes or  large cells (2) lymphocytes or small cells 
(3) mononuclear cells or middle cells 
 
Platelets can be counted using   same techniques of  electrical or 
electro optical deflection as are employed for counting red cells. Platelets 
can be counted between two fixed thresholds for example between 2 and 
20 fl. 
 Peripheral smear: 
Ideal smear should be tongue shaped with 4cm long and 2 cm wide 
was made and stained by Giemsa staining which contain basically 
mixture of acidic eosin y and contain basic stain of azure B thionin 
ESR is measured by Wintrobes method. The anticoagulation used 
is 3.8% trisodium citrate. 
 
CRP is calculated using a latex CRP reagent which consists of 
aqueous suspension of polysterene particles sensitized with a globulin 
fraction from anti CRP serum.  
 
 
 
Rheumatoid factor: 
Rheumatoid factor of IgM class can be detected and measured 
quantitatively by testing the ability of patient serum to agglutinate carrier 
particles coated with IgG. Polysterene particles coated with human IgG 
are used in the latex slide test. 
 
Bleeding time: 
It is calculated using filter paper  method. 
 Clotting time: 
It is calculated using  tube method 
 
Serum ferritin 
          Microplates coated with  anti human ferritin antibody will bind to 
ferritin from serum on the  coated plates and non bound component is 
removed with washing. Then “antihuman ferritin horseradish peroxidase 
conjugate” is pipeted which binds to ferritin and excess is washed off. 
With chromogenic substrate of  tetramethyl benzidine color develops and  
which is titrated by HCL. Amount of color developed  is proportional to 
the concentration of ferritin which is measured  by the optical density 
with a 450nm filter with micro plate reader. 
DAS 28 score 
Disease activity score is a composite score using tender and 
swollen joints count , ESR and patients global assessment activity using a 
100 mm visual analogue scale.  
 
DAS28=0.56 √(no.of tender joints) + 0.28 √(no.of swollen joints)     
                                  +0.70 log(ESR)+0.014(global assessment in mm). 
 
 
Classification 
Mild   <3.1  
Moderate 3.2-5.1   
Severe >5.1         ( Minimum score :0; Maximum score : 9 ) 
Parameters used in Disease activity score: 
(1) Total 28 joint count  for tenderness 
(2) Total 28 joint for swelling 
(3) ESR in mm in first hour 
(4) Patient assessment of global health using a 100mm visual analogue 
scale ranging from 0(very good) to 100 (very poor ) 
28 joint counts: 
(1) Shoulders (2) 
(2) Elbows (2) 
(3)Wrists (2) 
(4)MCP for 4 fingers (8) 
(5)MCP thumb (2) 
(6) PIP for 4 fingers and thumb (10) 
(7) Knees (2) 
         Data analysis was done using epidemiological information 
statistical software. Using the software the frequencies, mean , standard 
deviation and p values calculated with yate’s test for qualitative variables 
and kruskol walls chi square test for quantitative variables. p value <0.05 
is taken as  significant. 
 
         
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
   
 
 
  
 
 
 
            
 
 
 
 
 
 
 
 
 
 
 
 
 
 
   RESULTS AND ANALYSIS OF OBSERVED DATA 
 
                                               Table 1 
 
                                        Sex  Distribution 
 
Sl. no         Sex   N0. of patients   Percentage 
1 male 9 20% 
2 female 35 80% 
In this study out of  44 cases , 35 are females and 9 are males. 
The female are 80% and  males 20%.  
 
Table 2: Age distribution 
 
  
Cases Age group 
No. % 
20-29 years 5 11.4 
30-39 years 12 27.3 
40-49 years 16 36.4 
50-59 years 11 25 
Total 44 100 
Mean 
S.D. 
40.98 years 
 
9.73 years 
 
The age of the patients from 20-60 years with an average of 40 
years and more cases from 40- 49 years of age group. 
AGE   DISTRIBUTION 
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Table 3: DAS Score 28 
 
   
DAS Score 28 Cases 
Mild (< 3.1) 2 4.5 
Moderate (3.2-5.1) 23 52.3 
Severe ( > 5.1) 20 45.5 
Total 44 100 
Score 
Range 
Mean 
S.D.                             
 
2.75 -5.81 
         4.8 
        0.78 
 
This table shows that 2 people out of 44 (4.5%) had mild disease  
and 23 people (52.3%) has moderate disease. 20 people (45.5%) had 
severe disease. DAS 28 score ranges from 2.75 to 5.81 with a mean value 
of 4.8 with standard deviation 0.78 
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Table 4 : DAS 28 Score and Age   
DAS 28 Score  
Age group Mean S.D. 
20-29 4.8 0.5 
30-39 4.48 0.67 
40-49 4.52 0.69 
50-59 4.51 0.92 
‘p’ 0.8108 
Not Significant 
 
Analyzing the above data age group doesn’t correlate with disease 
activity and DAS 28 score 
 
                              Table 5 
                         Duration of illness 
   
 Duration of 
illness(in years) 
Range 
Mean 
S.D. 
1 – 5 
2.93 
1.13 
The duration of illness ranged from 1 year to 5 years with an average of 
2.98 years with a standard deviation of 1.13 years. 
All 44 cases(100% )fulfilled the revised criteria of American rheumatism 
association for rheumatoid arthritis 
 
All the cases distal joints involvement( distal interphalangeal joints 
are  spared) 14 cases had both proximal and distal joint 
involvement(31%). Joint deformity were present in 22 cases (50%) 
rheumatoid nodules were present in 3cases(6%). Episcleritis  was present 
in 3 cases(6%). Aortic Valve involvement was  in 2 cases (4%) 
Table : 6 
Rheumatoid factor positivity  
   
Cases  
Rheumatoid factor No. % 
%Positive 35 79.5 
Negative 9 20.5 
 
 Rheumatoid factor is positive in 35 cases (79.5%) and negative in  9 
cases (20.5%). 
 
Serum proteins were normal . There was no reversal of albumin / globulin  
ratio and there was no  hyperglobulinemia noticed in the study .Serum 
calcium and uric acid were normal in all patients. 
 
27 patients  showed radiological evidence of rheumatoid arthritis. 
No patients had splenomegaly or significant generalized 
lymphadenopathy. 
 
Concomitant usage of  NSAIDS  80% and corticosteroids 40% and 
methotrexate 4% was  present. 
 
           Anemia is defined as <11gm in females and <12gm in males  as in 
most of the studies  
 
Table No 7 
Anemia and rheumatoid arthritis 
 
 
 
 
 
Among the 44 cases  of rheumatoid arthritis 33 cases are anemic 
(75%) and not anemic in 11 case (25%)Mean hemoglobin level in 
patients was 10.67+1.83 
 
                
 
                                   
Sl. no  No of cases percentage 
1 Anemic 33 75% 
2 Not anemic 11 25% 
    Table No 8 
                  Anemia and rheumatoid factor positivity: 
 
  
Anemic 26/33 
Not anemic 6/11 
P value 0.0305  significant 
 
In patients who are anemic  , number of  rheumatoid factor 
positivity  was 87% and in not anemic patients rheumatoid factor 
positivity was only 54%. 
Mean Hb level in  rheumatoid factor positivity was 9.11 
gms+2.05s.d 
Mean Hb level in rheumatoid factor negativity was 10.23+1.19s.d 
When analysing the above values, anemia is one of the indicator of 
disease activity and severity of rheumatoid arthritis 
 
Anemia and ESR and Rheumatoid factor positivity 
 
Anemic and non anemic patients were comparatively studied with 
their erythrocyte sedimentation rate levels and seropositivity for 
rheumatoid factor. 
Out of 33 patients  32 patients have elevated ESR out of which 
rheumatoid factor positive in 29 patients (90.6%) whereas in 11 non 
anemic patients 10 had elevated ESR of which only 6 are rheumatoid 
factor positive (60%). The values suggest that the anemic patients have 
more elevation of ESR and percentage of rheumatoid factor positivity is 
also more in this group. 
  
Anemia with disease duration 
 
In 33 anemic patients 15 patients had more than 3yr duration (45%) 
whereas  in non anemic  11 patients  only 1 had (9%) had disease more 
than 3 year. When analyzing the above, the incidence of anemia 
correlated with the duration of disease. 
 
Table 9 : DAS 28 Score and duration of disease 
   
Duration of 
disease 
(in years) 
 
DAS 28 Score 
Mean S.D. 
Mild 2.0 - 
Moderate 2.83 1.17 
Severe 3.5 1.16 
‘p’ 0.0471 
Significant 
 
When analyzing the above charts DAS 28 score  was correlated very well 
with duration of disease. 
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Table10:  Anemia and DAS 28 Score 
   
DAS 28 Score  
Anemia Mean S.D. 
Absent 4.32 0.91 
Present 5.04 0.58 
‘p’ 0.0060 
Significant 
 
When analyzing the data incidence of anemia correlated with 
activity of disease and anemic patients had higher  DAS 28 score than 
non anemic patients. P value is significant. 
                      Table 11:Peripheral smear study 
Types of anemia and rheumatoid factor positivity 
 
 No.o
f pts 
percentag
e 
Rheumatoi
d positivity 
percentag
e 
Microcytic  
hypochromic 
8 18.2 8 100 
Normocytic 
normochromi
c 
20 45.5 17 85 
Dimorphic 5 11.4 4 80 
normal 11 25 6 54 
  
When analyzing the above data 8 patients ( 18.2% )patients show  
 
microcytic hypochromic anemia . Out of 8 patients all shows rheumatoid 
  
factor positivity. 20 patients (45.5%  ) shows normocytic  normochromic 
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 anemia. Out of 20 patients 17 patients (85%) were rheumatoid factor  
 
positive. 5  patients shows dimorphic anemia. Out of 5 patients 4 patients 
 
shows (80%) rheumatoid factor positive. But p value is 0.09 not  
 
significant. That means the type of  anemia  doesn’t correlate with 
 
 rheumatoid factor positivity . 
 Percentage of types of anemia in anemic patients: 
 Iron deficiency anemia 25% 
           Anemia of chronic disease 60% 
           Dimorphic anemia  15% 
Table 12 : DAS 28 Score and Peripheral Smear Study 
   
DAS 28 Score  
Peripheral Smear Study Mean S.D. 
Microcytic hypochromic anaemia 4.77 0.35 
Normocytic normochromic anaemia 5.38 0.46 
Dimorphic anemia 4.71 0.48 
Normal 3.8 0.51 
‘p’ 0.0001 
Significant 
 
 
When analyzing the above data anemic patients has more DAS 28 
score  than  not anemic patients. Patients with normocytic anemia   that 
means anemia of chronic disease has high DAS 28 score ( 5.38)  than iron 
deficient patients (4.77 ) p value is  significant 0.001 
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Table 13: DAS 28 Score and Rheumatoid Factor 
   
DAS 28 Score  
Rheumatoid factor Mean S.D. 
Positive 4.98 0.61 
Negative 4.01 0.53 
‘p’ 0.0025 
Significant 
 
When analyzing the above data rheumatoid factor positive patients have 
higher DAS 28 score than rheumatoid factor negative patients 
                              Table 14: 
Serum ferritin and DAS 28 score 
 
 
 
 
 
 
 
 
The table shows that ferritin value correlates with severity of  rheumatoid 
arthritis. 
 
 
DAS 28 sore Serum ferritin( mean &S.D ) 
Mild 50+24.5 
Moderate 52.73+34.77 
Severe 151.5+88.9 
P VALUE 0.001 significant 
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 Packed cell volume; 
Mean value 34 + 5.3  
 
<20%       -1 patient  -2% 
 
          20-30%   --9 patients -20% 
 
30-40%  -22 patients -50% 
 
>40%     -5 patients    -11% 
 
Table 15: 
 
Clinical and laboratory features of anemic and non anemic patients: 
In this study MCV and Hb and MCH an MCHC has higher values in 
anemic patients  than non anemic patients .p value was significant . In 
DAS  28 score we are using the variables like  swollen joints and tender 
 Anemic patients Not anemic 
patients 
 
 Mean S.D Mean S.D P value 
Tender joint 
count, 
10.4 5.45 5.27 3.85 0.004 
significant 
Swollen joint 
count 
6.5 3.78 3.28 4.82 0.oo6 
significant 
Visual 
analogue 
scale 
66.10 53.1 31.2 43.3 0.005  
significant 
Hemoglobin 9.72 1.43 12.49 0.75 0.0001 
significant 
Mean 
corpuscular 
volume 
78.27 8.87 86.42 5.3 0.0036 
significant 
Mean 
corpuscular 
hemoglobin 
24.51 3.63 27.92 2.2 0.0033 
significant 
Mean 
corpuscular 
hemoglobin 
concentration 
31.08 1.73 32.27 0.81 0.0071  
significant 
joints  and visual analogue scale  and ESR. ESR already shows the highly 
significant correlation with anemia and rheumatoid factor positivity and 
disease activity. Swollen joints and tender joints and visual analogue 
scale with anemia correlation was highly significant. P value was <0.05 
                                             Table 16: 
 
Clinical and laboratory features of iron deficient anemic and 
anemia of chronic disease patients 
 IDA Patients  ACD Patients  P value 
 Mean S.D Mean  S.D  
Tender joint 
count  
5.54 3.57 10.55 7.40 0.006 significant 
Swollen joint 
count 
4.01 2.78 7.65 5.43 0.006 significant 
Visual 
analogue 
scale 
41.12 48.08 78.12 45.87 0.002 significant 
hemoglobin 8.6 1.81 10.91 0.82 0.0019 
significant 
Mean 
corpuscular 
volume 
76.84 5.87 83.97 5.0 0.002 significant 
Mean 
corpuscular 
hemoglobin 
21.22 3.01 26.93 1.86 0.003 significant 
Mean 
corpuscular 
hemoglobin 
concentration 
29.8 2.01 31.83 1.3. 0.0032significant
 
 
This table tells that Hb  , MCV and MCH  and MCHC  are lower in 
Iron deficiency anemia than anemia of chronic disease. Tender joint 
count and swollen joint count and visual analogue scale  also lower in 
iron deficiency  anemia than anemia of chronic disease. P value was 
significant in all variables. 
 
 
WBC count: 
 
Out of 44 patients 13 patients have leucocytosis (29.5%). No 
patient had leucopenia. 
 
Neutrophils: 
 
50-70%- 8 patients  -18% 
 
>70%-36 patients    -82% 
 
Neutrophilia is present in 36 patients. 
 
Lymphocytes:. 
 
<20%-10 patients   -23% 
 
20-30%-18 patients -41% 
 
>30%-16 patients   -36%  
 
Lymphopenia is present in23% of patients. 
 
 
 
 
Eosinophils: 
 
12patients (27%) have eosinophils >6%. All 12 patients are 
rheumatoid factor positive. 
No patients had immature cells or large granular lymphocytes. 
 
Thrombocytes 
Table 17: 
Platelet count and rheumatoid factor positivity 
 
 
When analyzing the above data thrombocytosis indicates disease 
activity. P value was significant 0.04. 
Table 18  
Relationship between DAS 28 Score and other parameters 
 
Value for cases with DAS 28 Score 
Mild Moderate Severe 
 
Parameter 
mean S.D. mean S.D. mean S.D.
 
‘p’ 
PLT 2.75 1.35 3.49 0.93 4.09 0.97 0.0046 Significant 
Eosinophil. 1 1.4 2.39 3.25 6.7 5.76 0.0001 Significant 
CRP 6.8 5.5 23.13 24.5 53.85 19.9 0.0006 Significant 
Ferritin 50 2.3 52.73 34.7 151.5 88.9    0.001 significant 
ESR 25 14.1 43.24 12.2 67.25 25.5 0.0001 Significant 
 
When analyzing the above data ESR and CRP, platelet count and 
eosinophil count and ferritin are  well correlated with disease activity . 
that means if ESR and CRP and platelet count and eosinophil and ferritin 
was high  ,disease activity and DAS28 score was also high. All the other 
parameters doesn’t correlate with  DAS 28 score. 
 
 No. of 
patients 
Rheumatoid 
factor positive
percentage 
>4 lakhs 14 12 85% 
<4 lakhs 30 23 76% 
Bleeding time ; 
Normal in all patients. 
 
Clotting time 
Normal in all patients. 
 
No patients had features of  hyperviscosity syndrome and no 
patient had a features of Felty syndrome and no patient had a feature of 
pure red cell aplasia and  no lymphoma and leukemia. 
 
 
 
 
        
 
 
 
 
 
 
 
 
 
 
                                      
 
 
 
 
 
 
 
 
 
 
 
                                     DISCUSSION 
 
 
 
Rheumatoid arthritis is a chronic, systemic, inflammatory disorder 
of unknown etiology that is a pattern of diarthrodial joint involvement. Its 
primary site of pathology is the synovium of joints. The rheumatoid  
factor positivity and extra articular manifestations commonly accompany 
the joint disease , but arthritis is the major manifestation. 
  In our study we selected 44 cases of rheumatoid arthritis on 
random basis  as per the American rheumatism association guidelines 
1987. 
The sex distribution  in this study , is  predominantly affects 
females in a ratio of 4:1.According to  Harrison 17th edition, API text 
book of medicine  that the women are affected  3 times more than male. 
In this  study males are 20% and females are 80%. Doran Mf, Ponal    Gr  
et al (35) in his study males are 26.9% and females are 73.1%. Mean age is 
58.5 years. In our study is 40.98 years. 
Alamonsky, Yougari , Drosos et al (36) in his study  the risk of developing 
disease is greatest between 40 and 50 years. In our study  the risk also is 
between 40 to 49 years around 36.4 %. 
Navarocaro Gregio et al (37)and Abach, R.R. Buchanan et al (38) in 
their study the severity of disease is in  positive  correlation with duration 
of disease. In this  study patients who had disease more than 3 year have 
more  DAS 28 score .The p value is significant and this shows that  
duration of disease is directly proportional to the severity of disease. 
B.Fleeb, L.Andel, J.Sautner et al (39), in their study the mean  DAS 
28 score was 4.23+1.2 .In this  study mean  DAS 28 score was 4.8+0.78. 
Toshihisomatsui   et al (40 )in their  study  reported 11.6% patients  had 
mild DAS 28 score and 51.4% has moderate DAS 28 score and 37.4% 
patients had severe DAS 28 score. In this  study patients with mild DAS 
28  was around 4.5% and moderate score was 52.3% and severe 45.5% .  
This states that most of the patients  are in moderate severity. 
Card Richard et al (41) in his study rheumatoid factor positivity was 
80% and negativity 20%. In this  study  RF positivity was 79.5% and 
while  20.5% RF was negative . The ratio of rheumatoid factor positivity 
to negativity is 4:1 
Tracey Houston  et al (42)in their  study ,mean hemoglobin  in 
rheumatoid arthritis patients was 9.57 gm% and in this study mean Hb is 
10.6gm%. 
M. Kar, S. Roy et al (43)in their  study, mean hemoglobin  level in 
rheumatoid positivity patients was 9.57gm% and 10.45gm%. among 
rheumatoid negative patients. In this study mean Hb level in rheumatoid 
factor positive patients  is 9.11+2.05 and mean Hb among  rheumatoid 
factor negative  is 10.23+1.19 gm%. 
D.J. Borah ,Farhis Iqbal et al (44) in their  study ,out of 20 anemic 
patients 18 patients were rheumatoid factor positive (90%) and in non 
anemic patients out of 11 patients 6 patients (54%) were rheumatoid 
factor positive. In this study , out of 33 anemic patients 29 patients are 
rheumatoid factor positive ( 87%) and in non anemic 11 patients  patients, 
6  (54%) are rheumatoid factor positive. This states that anemia is very 
well correlated with rheumatoid factor positivity and disease activity. 
Agarwal Sumeet et al(45) in their study, mean DAS 28 score in non 
anemic patients was 3.83 compared to   anemic patients which was 5.13. 
In this  study in non anemic patients mean DAS  28 score is 4.32 and in 
anemic patients 5.04. D J Borah , Farhis Iqbal et al (44) in their study, in 
non anemic patients mean DAS 28 score  was 4.76 while  anemic patients 
it  was  6.85.This states that anemic patients have  more DAS score and 
disease activity than non anemic patients. 
Distinguishing ACD from iron-deficiency state in the setting of 
chronic inflammatory process is difficult. Serum ferritin is a reliable 
parameter to predict bone-marrow iron stores in uncomplicated anemic 
states. 
However, in chronic inflammation, ferritin is increased as a part of 
acute-phase reaction and hence determining a cutoff level to differentiate 
between iron-replete and depleted state becomes difficult. The value of 
serum ferritin indicative of iron-deficient state in various studies range 
from 30 to 70 µg/l [46, 47]. We have taken a value of 50 µg/l as an indicator 
of iron-deficiency in our study as it has been shown to have a specificity 
of 81% and sensitivity of 100% [23]. Bone-marrow iron staining is 
considered as the gold-standard in such conditions. However, the 
procedure is invasive, time-consuming and expensive. Two recent studies 
have shown that absent bone-marrow stainable iron may not truly be 
representative of iron deficiency (48). 
 
Soluble transferrin receptors (sTfR) level has been found to be 
useful in distinguishing iron deficiency from ACD as it does not behave 
as an acute-phase reactant. A high sTfR level although indicates iron-
deficient erythropoiesis, it does not necessarily indicate iron deficient 
state. A serum ferritin of  50 µg/l is as sensitive as sTfR in predicting 
iron-deficiency [23]. However a combination of high sTfR ( > 2.5 mg/l) 
and low ferritin ( < 50 µg/l) levels or a ratio of sTfR to log ferritin gave 
higher specificity ( > 90%) than either of them alone in predicting IDA in 
RA [23]. It may also help differentiate patients with mixed anemia from 
pure ACD which is probably the most common in patients with RA. 
  Agarwal Sumeet et al (45),in  their  study, of rheumatoid arthritis   
patients with iron deficiency anemia  DAS 28 score was 4.7 and in 
patients with  anemia of chronic disease  DAS 28 score was 5.69 . In this 
study patients   with iron deficiency   DAS  28 score was 4.77 and in 
anemia of chronic disease was  5.38. The p value  is significant( 0.001) 
.This states that DAS 28 score is higher in ACD than in IDA.  
 
 
 
 
 
             
        Anemia was defined as hemoglobin level of  11 g/dl in female and  
12 g/dl in male patients the prevalence reported in RA patients from 
Western countries [49] which varies from 33.3 to 59.1% although the 
cutoff hemoglobin value used to define anemia in these studies was 
higher than our study. 
Most of the above studies used a definition of anemia close to that 
suggested by World Health Organization (WHO) while we have used a 
definition lower than that. Despite this we find that the prevalence of 
anemia is considerably higher. If the WHO criterion had been used (men 
Hb  13 g/dl and women  12 g/dl) then the prevalence of anemia in our 
cohort would be 84.1%. 
This is possibly related to high background prevalence of anemia in 
general adult Indian population as well as poor access to medical care 
leading to poor disease control of RA. 
 Anemic patients % 
        This  study 75% 
        Peters et al (49) 64% 
        Baer etal(12) 76% 
 Remacha et al (51) 55% 
   Hotchberg et al (52) 40% 
         Baer et al (53) 27% 
         Segal et al (54) 49% 
 Types of anemia and rheumatoid arthritis 
 
In this  study iron deficiency anemia patients are less (24.5%)   
because  iron deficient anemia with inflammation(Dimorphic anemia )is 
included separately(15%)  and  there is  a probable folic acid  and/or Vit 
B12 deficiency .  
Microcytosis (<80 femtolitre) in this study is 27% patients among 
rheumatoid arthritis patients .Alexander et al (8) in their  study showed 
30% prevalence of microcytosis . 
Hypochromia (less than 26pg) is present in 38% of  rheumatoid 
arthritis patients in  this study. Caris J Bastley et al (55) reported   50% 
hypochromia in their study. 
Kadir et al (56) in his study, mean ESR was 36.6+23.5 .In their 
study  ferritin was 121.3 +34.2 ,and ESR ,CRP  and ferritin showed 
significant  correlation  with disease activity as well as  DAS 28  score . 
The p value was  significant <0.001. In this study mean ESR is  
53.5+22.3 and ferritin is 99.5+80.93 and ESR, CRP and  ferritin are  very 
 Peter et(49) JK sci (44) Agarwal(45) This  study
ACD 65% 60% 51.6% 60.5% 
IDA 23% 40% 48.4% 24.5% 
Dimorphic 12% --- ---- 15% 
well correlated with disease activity and the p value was 0.006 for ESR  
and  0.0001 for CRP and ferritin respectively . 
Sumeet Agarwal et al (45) and D J Borah , Fahler Iqbal et al (44) in 
their study, the variables  used in calculating DAS 28 score  like tender 
joint count , swollen joint count , ESR and visual analogue scale was 
correlated significantly.  The p value  was more significant  in anemic 
patients than non anemic patients .In this study also all the 4 variables 
shows  high significance  in anemic patients compared to  non anemic 
patients. 
Agarwal et al (45)  in their study;  tender joint count ,  swollen joint 
count , ESR and visual analogue scale in patients with  anemia of chronic 
disease showed  higher value than  iron deficiency anemic patients. 
Similar results  were obtained in all the variables  showing  higher 
significance  in  patients with  anemia of chronic disease  than iron 
deficiency anemic patients in this study. The p  value  is significant. 
 
 Hutchuson et al (57) and Dulaguist  et al (58) in their study 
thrombocytosis in rheumatoid arthritis was 52% and 60% respectively 
Alof Selross et al (59) in their  study ;thrombocytosis  was present in 33% 
of patients and it  correlated with disease activity. In our study  
thrombocytosis is present in 31%. Patients with thombocytosis  have  
higher DAS 28 score with significant  p value . 
  M.Kar , S.Roy et al (43) in their study ;eosinophilia was present in 
20.45% of rheumatoid arthritis patients. R J Windchester et al (60) and 
Short Bauer  et al (61) in their study eosinophilia was present in 40% and 
10% of patients of rheumatoid arthritis respectively which correlated 
with disease activity . In this study eosinophilia is  present in 27% 
patients  which correlated very well with DAS 28  score and disease 
activity with significant p value . 
 M.Kar S.Roy  et al( 43) in their study leucocytosis was present in 
20.7% and leucopenia was present in 11.1% patients  and lymphopenia 
was  present in 6% patients. In  this study 29.5% patients have 
leucocytosis. None of the patient had  leucopenia .Lymphopenia is 
present in 23% patients. Leucopenia is lacking   in this  study because  
we didn’t take  patients  with longer duration disease for study group and 
lymphopenia  is present higher than M.Kar S.Roy   study ,probably   due 
to steroid therapy .  
 
Luis A, Toro Jimenez et al (62) in their  study of  214 rheumatoid 
arthritis patients  12 patients had M spike with mean age of M spike 
being  69 years. IgG gammopathy was present in 50% patients.  1 patient 
was diagnosed as multiple myeloma and 1 patient  had a primary 
lymphoproliferative disorder . One  patient diagnosed as a T cell 
leukemia and 4 patients  diagnosed as a myelodysplastic syndrome and 4 
patients were  diagnosed to have  monoclonal gammopathy . 
In this study no patient has hyperglobulinemia and myelodysplastic 
syndrome, leukemia or lymphoma or multiple myeloma and no patient 
had a large granular lymphocytosis syndrome. 
Agarwal Sachdev et al  (63) reported pure red cell aplasia  and 
immune thrombocytopenia. In this  study no patients had 
thrombocytopenia and pure red cell aplasia. No patient had decreased red 
cell distribution width . 
Abach , R,R,Buchnan et al(38) reported a hyperviscosity syndrome 
in rheumatoid  arthritis. In this  study no patient had symptoms 
suggestive of hyperviscosity syndrome  
Paraiaz , Fayaz etal (33) study none of the  patient of rheumatoid 
arthritis had  evidence of bleeding and DIC. Only isolated abnormalities 
of coagulation was present. Protein C and protein S was low in 1case  
each while   decreased factor VIII level was detected in 5 cases. 
Hypofibrinogenemia was demonstrated  in 1 case. All patients had 
normal factor IX level.  In this study no patient had  evidence of bleeding 
and  abnormal bleeding time  as well as clotting time. 
 
 
 
 
                              CONCLUSION 
 
(1) Sex  ratio of females to males is this study is  4:1 
     (2)The risk of developing disease is greatest between 40 to 49 years .   
     (3)  Rheumatoid factor positivity is 80% and rheumatoid factor  
          negativity is 20% 
     (4)The prevalence  of anemia in rheumatoid arthritis patients is 75% 
 
     ( 5) In rheumatoid factor positive patients mean Hb values is   less  
            (9.11gm%) compared to rheumatoid factor negative patients 
            (10.23gm%). Iron deficiency anemia  patients mean Hb is 
            lower(8.6gm%) than in  anemia of chronic disease  is (10.9gm%). 
 
     (6)The prevalence of  rheumatoid arthritis according to DAS 28 score 
          categories in decreasing order are  moderate 52.3% , severe 45.5%  
           and mild 4.5%. 
 
(7) Anemia is very well correlated with rheumatoid factor positivity ,  
     disease activity (DAS 28 score ) ,duration of disease   and   ESR. 
 
(8) Microcytic hypochromic anemia ( iron deficiency anemia ) is    
      present in 25% of anemic patients and anemia of chronic disease   
     (normocytic normochromic) anemia is present in 60% of anemic 
     patients and dimorphic anemia in 15% anemic patients. 
 
(9)Patients with anemia of chronic disease have  higher disease 
activity ( DAS 28 score) than iron deficiency anemia patients in 
rheumatoid arthritis . 
 
(10) Rheumatoid factor , ESR, CRP and  ferritin  positively correlates 
with DAS 28 score significantly.. 
 
(11) Thrombocytosis  is present in 31% of patients and eosinophilia is 
present in 27% of patients  and very well correlated with DAS 28 
score.  
 
(12) 29.5% have  leucocytosis.while none of the patients have  
leucopenia . Lymphopenia is  present in 20% of RA patients.  
 
(13) Bleeding time and clotting time are normal  among all patients . 
 
 
 
 
                       
                                             
 
 
                                    SUMMARY 
          The study “Hematological Profile in Rheumatoid arthritis ” is  a 
cross- sectional study conducted on  patients visiting the outpatient 
Department of Rheumatology ,Government Rajaji Hospital , Madurai.  
Forty four patients with rheumatoid arthritis fulfilling the criteria of 
American rheumatologist association criteria ( 1987) were  included in 
the study. Selected patients underwent clinical , and laboratory 
evaluation to detect the hematological abnormalities in rheumatoid 
arthritis patients and DAS 28 score was calculated which indicates the 
disease severity. It has been   observed that  anemia is the one of the 
indicator of disease severity and anemia incidence is more in South 
Indian   patients than European Population. Anemia of chronic disease 
is more common compared to  iron deficient anemia among 
rheumatoid arthritis patients . Anemia of chronic disease has higher 
DAS28 score than iron deficiency anemia as observed are in this 
study. It was also observed that  thrombocytosis and eosinophilia also  
the indicators of disease severity which  positively correlated with 
DAS 28 score; like ESR, CRP , rheumatoid factor and ferritin. 
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   GLOSSARY 
 
ACD       - Anemia of chronic disease 
 
CRP        -  C reactive protein  
 
DAS        - Disease activity score 
 
DIC      - Disseminated intravascular coagulation 
 
ESR             - Erythrocyte sedimentation rate 
 
Hb               -  Hemoglobin 
 
IDA            -  Iron deficient anemia 
 
MCV         - Mean corpuscular volume 
 
MCH      - Mean corpuscular hemoglobin 
 
MCHC         - Mean corpuscular hemoglobin concentration 
 
PCV          -  Packed cell volume 
  
PDW         - Platelet distribution width 
 
RA             - Rheumatoid arthritis 
 
RBC           - Red blood cell  
 
RF             -  Rheumatoid factor 
 
RDW       -  Red cell distribution width 
 
sTfr            - Soluble transferrin receptor 
 
TIBC           -  Total iron binding capacity 
 
WBC          -  White blood cell count 
 
%sat       - Percentage of saturation 
 
PROFORMA 
 
Name:                                                                age                           sex 
 
Address:                                                                        occupation 
 
 
Symptoms                                             duration 
 
(1)        joint pain  
(2)        joint swelling 
(3)        fever 
(4)        morning stiffness 
(5)        edema 
(6)        loss of weight 
(7)        loss of appetite 
(8)        muscle pain  
(9)        back pain  
(10) recurrent infection 
(11) easy fatiguability 
(12) breathlessness 
(13) bleeding manifestations 
 
Past History 
 
HT                    DM                         IHD                                 TB 
 
Personal history: 
 
Smoking                            alcohol                       veg/nonveg 
 
Education                            urban / rural 
 
Drug H/O 
 
Nsaids/ diuretics/steroids/immunosuppressants/ others 
   
G/E  pallor                              lymphadenopathy                          jaundice 
         
        Nodule                               ulcer                               dry eyes 
 
Rash                           pedal edema                  skin infections 
 
Temp                PR                        RR                           BP 
 
 
Joint swelling Joint tenderness 
 right left right left 
 
 UL LL UL LL UL LL UL LL 
1         
2         
3         
4         
PIP 
5         
1         
2         
3         
4         
MCP 
5         
wrist      
shoulder      
elbow      
knee      
 
TM joint                                        SI joint                                   spine   
cervical 
                                                                                                                 
Thoracic 
                                                                                                                   
Lumbosacral 
 
Stage of progression Xray wise stage;                                Joint deformities: 
 
Swelling joint count: 
 
Tender joint count 
 
Visual analogue scale      0---------------------------------------100    
   
 
Functional class        I              II                  III                 Iv 
 
Other system examination 
 
 
 
 
 
 
Psychiatry anxiety / depression 
 
Investigations: 
 
RBc                      WBC                         Platelet 
HB                         DC                            MPV 
HCT 
MCV 
MCH 
MCHC  
RDw 
 
Serum ferritin  
TIBC 
Serum iron 
 
Peripheral smear 
 
BT                              CT 
CVS normal pericarditis myocarditis endocarditis Aortitis 
RS normal Pleual 
effusion 
ILD bronchilitis 
abdomen Normal  hepatomegaly splenomegaly ascites 
eyes normal sicca scleritis episcleritis scleromalacia
CNS normal Cranial nerve 
palsy 
Peripheral 
neuropathy 
quadriplegia 
ESR                                           CRP                              Rh factor 
Sugar                               urea                           creatinine 
Total protein                     albumin                     globulin 
 
DAS  28 score 
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p
s
1 50 f 6.8 2.72 21.4 78.5 25 31.8 18.2 5.09 12,100 71 8 17 3 13.8 7.3 5.5 13 370 4 45 4.38 p 3 mh
2 29 f 9.4 4.41 30.1 68.2 21.4 31.4 18.8 4.38 7100 71 3 19 7 55.7 7.6 7 9 271 3 115 5.17 p 4 mh
3 35 f 12.4 4.32 37.7 87.4 28.8 33 16 3.84 20900 64 1 32 3 16.3 8.3 63.2 47 314 15 40 4 p 1 n
4 51 f 8.6 4.36 29.6 68 19.7 29 20.9 4.66 11500 76 10 9 5 90.5 9 31.8 5 323 2 60 5.12 p 2 mh
5 55 f 10.7 4.06 33.5 82.3 26.3 32 20.5 3.88 12200 72 1 22 5 9.4 6.9 48.5 36 362 10 30 4.24 n 3 da
6 47 f 10.4 3.52 31.9 90.8 29.7 32.8 15.3 5.14 6300 56 15 29 0 69.4 9 216 44 330 13 50 5.71 p 4 nn
7 20 f 10 3.78 30.3 80.4 26.5 32.9 15.1 5.16 9700 61 9 28 2 63.9 9.4 206 20 324 6 75 5.69 p 2 nn
8 58 m 11 3.72 35.4 95.1 30.2 31.7 14.8 5.97 9000 53 20 27 0 63.1 8.4 90 205 354 58 50 5.57 p 3 nn
9 52 m 11.6 4.18 35.2 84.2 27.7 32.9 16.4 3.09 11200 75 3 17 5 11 8.2 63 139 400 35 15 4.42 n 2 nn
10 59 m 12.1 3.74 35.8 95.8 32.3 33.7 13.9 2.75 5200 68 0 27 5 2.9 8.1 119 79 256 31 15 2.75 p 2 n
11 48 f 13.6 4.45 40.8 91.7 30.5 33.2 14.1 2.36 9400 69 3 24 4 2.9 9.4 78 64 358 18 35 3.75 n 2 n
12 56 m 11.4 4.5 41 91.2 29.8 32.7 14.6 4.02 15600 70 10 16 4 41.3 8 306 46 302 15 115 5.74 p 4 nn
13 34 f 10.7 4.45 37.1 83.3 26.6 32 16.6 3.84 10100 65 0 29 6 52.9 7.8 180 34 558 6 100 5.21 p 1 nn
14 47 f 10.8 4.58 38.4 83.8 26.7 31.9 17 3.47 9200 60 15 24 1 62.9 8.9 175 158 407 39 80 5.46 p 3 nn
15 54 f 10.7 4.01 33.5 83.6 26.6 31.9 15.6 4.62 10500 87 0 13 0 75.9 7.3 50.2 28 350 8 40 4.38 n 4 nn
16 50 f 10.7 4.18 34.9 83.5 25.6 30.6 17.2 4.12 9400 60 7 31 0 61.3 9.4 221 19 502 4 60 5.81 p 4 nn
17 40 m 11.3 4.18 35 83.7 27 32.2 15 4 5600 60 2 32 0 22.6 9.1 116 20 371 5 40 5.67 p 2 nn
18 36 f 8.3 4.08 29.2 71.5 20.4 28.6 20.4 5.45 14900 70 11 14 5 61.3 9.1 5 6 409 1 65 5.22 p 5 mh
19 41 m 12.8 5.11 41.6 81.4 25.1 30.8 17.5 4.03 10900 67 2 26 5 8.8 7.3 97 27 406 7 45 3.85 n 2 n
20 35 f 7 4.31 26.8 62.3 16.2 26 22.6 2.68 5200 91 1 7 1 50.1 9.6 5.8 6 472 1 40 4.69 p 5 mh
21 35 f 10 4.81 37.1 83.3 26.7 26.6 16.2 2.65 6800 58 3 36 3 31.3 9.4 209 46 425 11 40 5.41 p 4 nn
22 40 f 11.8 4.84 38.4 79.3 24.4 30.8 17.1 4.4 16700 64 8 24 4 60.3 8.4 5.2 150 452 33 90 5.24 p 3 da
23 48 m 14.2 4.77 43.9 92.1 29.7 32.3 15.2 3.3 10600 78 0 17 5 2.9 7.4 67 76 377 20 35 3.08 n 2 n
24 40 m 12.7 4.65 39.5 89 28.6 32.2 13.7 2.7 8600 77 1 17 4 2.9 8.8 88 26 349 7 35 3.3 n 1 n
25 40 f 9.2 5.18 30.9 59.6 17.8 29.8 23.9 3.67 7300 67 1 26 6 2.9 8.9 19.7 28 358 8 45 4.21 p 3 da
26 50 m 12.1 4.01 37.6 93.8 30.1 32 15.9 3.65 9200 68 1 28 3 3.1 9.5 73 41 365 11 45 4.03 p 2 n
27 40 f 13.3 4.57 39.5 86.2 27.1 31.4 17 4.56 9200 57 2 32 9 80.7 7.5 68.7 40 326 12 60 4.69 p 4 n
28 20 f 10.8 4.62 41.4 89.6 28.8 32.1 13.9 3.23 12900 79 1 17 3 65 8.7 163 55 275 20 80 5.71 p 1 nn
29 24 f 12.4 4.83 38.8 80.2 25.7 31.8 17.1 3.7 8600 66 1 29 4 2.9 8 7.8 31 477 6 60 4.37 p 3 mh
30 47 f 10.9 2.12 35.1 85.3 27.3 32 18.3 3.22 10100 59 1 35 5 77.1 7.9 277 19 286 7 45 5.63 p 4 nn
31 25 f 11.9 4.23 36 85 28.1 33.1 12.2 3.34 10000 58 1 40 1 3 7.3 93 78 380 20 60 5.33 p 2 nn
Master Chart
32 40 f 6 3 19.4 65 20 30.9 16.6 5.53 12400 50 15 32 3 60.7 7.9 47 39 280 14 65 5.1 p 3 da
33 40 f 12.3 4.54 38.3 84 27 32 13.5 2.56 10700 58 2 39 1 3.1 7.8 65 78 349 23 60 4.12 p 2 n
34 35 f 10.4 4.18 32.6 78 24.8 31.8 14.7 5.3 14900 62 10 27 1 63 7.2 233 20 370 6 65 5.43 p 4 nn
35 36 f 10.3 3.75 31.9 85 27.5 32.3 12 2.4 8000 58 1 41 0 41 7.1 53 47 420 11 35 4.62 n 3 nn
36 34 f 10.6 4.26 34 80 24.8 31.1 15.8 2.52 11200 51 6 36 1 51 8.3 175 44 330 13 70 5.53 p 4 nn
37 34 f 10.9 4.44 35.4 80 25.1 31.5 14.2 4.66 16300 72 2 26 0 10.7 6.6 110 79 256 31 35 4.78 n 2 nn
38 40 f 8.7 3.87 28.2 73 22.4 30.7 15.6 2.62 7600 62 2 35 1 45.8 7.1 11.4 139 300 46 60 4.74 p 5 da
39 50 f 10.2 3.89 30.6 80 26.3 33.4 12.6 3.14 5000 55 1 43 1 51 7 160 28 350 8 40 5.78 p 2 nn
40 46 f 9 4.49 30.9 69 20.1 29.1 19.2 3.33 10800 55 2 42 1 25 8 5 13 420 3 45 4.63 p 4 mh
41 40 f 9.9 4.34 31.7 73 22.7 31.1 15.7 3.72 9800 55 1 43 1 30.3 6.9 162 46 340 14 45 5.69 p 4 nn
42 30 f 12.6 4.98 28.3 80 26.2 32.8 12.5 2.5 15300 70 0 27 3 5 8 59 47 318 15 35 4.03 p 3 n
43 37 f 7.3 3.42 23.7 69 21.3 30.7 15.1 3.18 5600 68 5 26 1 37.1 8.1 7 10 340 3 55 4.57 p 4 mh
44 35 f 10.3 4.11 31.6 80 25.1 32.7 12.9 2.41 5600 58 1 40 1 20 7.5 120 64 356 18 35 3.77 p 2 n
